// App-Quantinova.ai

1617 : A Phase Ib Trial of Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphoma (PTCL): The Ro-CHOP Study

Researchers

Presenter

  • Rene-Olivier Casasnovas

Principal Investigators

  • Herve Ghesquieres

  • Franck Morschhauser

  • Herve Tilly

  • Catherine Thieblemont

  • Vincent Ribrag

  • Bertrand Coiffier

Medical Centers

  • Haematology Clinic, CHU Le Bocage, Dijon, France

  • CRLCC Henri Becquerel, Rouen, France

  • Unite Hemopathies Lymphoides, AP-HP Hopital Henri Mondor, Creteil, France

  • Department of Nephrology, CHU Lille, Lille, France

  • Hematologie Adultes, Hopital Saint-Louis, Paris, France

  • Institut Gustave-Roussy, Villejuif, France

  • Onco-dermatology unit, Centre Leon Berard, Lyon, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral T-cell lymphoma

  • Cutaneous T-cell lymphoma

  • Acute Coronary Syndromes

  • Deep vein thrombosis

  • Venous thrombosis

  • T-cell lymphoma

  • Pulmonary edema

  • Arrhythmia

  • Lymphomas

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Vincristine

  • Doxorubicin

  • Prednisone

  • Romidepsin

Outcome

  • N/A

Study Design

  • pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved